Johnson & Johnson COVID-19 Vaccine Approval Expected Soon

  A panel of US experts recommended Johnson & Johnson's one-dose Covid-19 vaccine for emergency approval, resulting in a third vaccine that could begin shipping to countries hardest hit by the pandemic.

 

The 22 members of the committee were convened by the Food and Drug Administration and included leading scientists, as well as representatives from industry and consumers.

 

An emergency use authorization (US) is likely to be filed, likely in the next few days, making the J&J vaccine the third to receive the green light in the United States after Pfizer and Moderna were tentatively approved in December. .

 

"We have all seen the news about the Johnson and Johnson vaccine today, the third safe and effective vaccine," said President Joe Biden from Houston shortly after the vote.